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cal Thrombolysis of Iliofemoral Deep Vein Thrombosis
Eric S. Hager, MD, Luke Marone, MD, Robert Rhee, MD, Jae Cho, MD,
Michel Makaroun,MD, Rabih Chaer, MDUniversity of PittsburghMedical
Center, Pittsburgh, Pa
Objective(s): The long term effect of pharmacomechanical thrombol-
ysis (PMT) on venous patency and valve function are not known. Our
objective was to examine the long-term anatomic and functional outcomes
of PMT for iliofemoral deep vein thrombosis (IFDVT).
Methods: A retrospective review of all patients with symptomatic DVT
treated between 2006 and 2010 with PMTwas performed. All patients were
treated by a combination of local tissue plasminogen activator (tPA) with the
Angio-jet or Trellis® device. Catheter-directed thrombolysis (CDT) was
used selectively for residual thrombus.
Results:Ninety limbs were treated in 69 patients whowere amean age of
50 years (range 18-83). Patients presented with pain (67%) swelling (17%) and
phlegmasia (6%) averaging 12 days in duration (range 1-48 days); with a mean
follow-up of 22 months (range, 3-39 months; Table). All patients were treated
with PMT, but 49 (71%) required additional CDT. The iliac vein was stented in
42% of patients. Successful lysis (50% lysis) was achieved in 92%, with symp-
tom resolution in 98% of patients initially and in 94% at follow-up. There were
two DVT recurrences necessitating reintervention at 5 and 20 days, both
secondary to premature discontinuation of anticoagulation. The averageVillalta
score at the latest follow-up was 3, with 74% of patients having preserved valve
function by duplex imaging. Mild persistent/chronic clot was seen in 32% on
follow-up duplex imaging, but the overall vein patency was 91% with no deep
venous reflux. Two asymptomatic iliac stent thromboses did not require rein-
tervention. Patients treated with isolated single setting PMT (group A, n 20)
had similar long termoutcomes as those needing additionalCDT (groupB, n
49), with equally sustained clinical improvement and an average Villalta score of
3 and an average CEAP score of 1 (P  NS) in both groups. The overall vein
patency rates were 90% vs 92%, despite a higher percentage ofminor persistent/
chronic clot in group A (40%) vs group B (24%) on duplex follow-up imaging.
Conclusions: Isolated single setting PMT and PMT with CDT are
equally effective and durable for the treatment of iliofemoral DVT, with low
rates of recurrence, and good long term physiologic and functional outcomes.arly Experience With Mechanical Chemical Ablation of the Great
aphenous Vein
ennifer Heller; MD, Johns Hopkins Bayview Medical Center, Baltimore, Md
Objective(s): Mechanical chemical ablation (MECA) of the super-
cial axial venous system has recently been introduced as a novel device
hat eliminates potential nerve injury and is tumescence free. This study
xamined early perioperative and postoperative outcomes using MECA.
Methods: Fifteen patients (14 women, 1 man) with symptomatic
uperficial venous insufficiency were consecutively invited to undergo
ECA. All patients demonstrated refractory symptoms despite conservative
anagement and significant reflux of the great saphenous vein (GSV) by
enous reflux examination. Patients were a mean age of 52 years (range
3-67 years). MECA was performed using the ClariVein® device with 1.5%
otradecol sclerosant. Intravenous conscious sedation was administered.
he mean venous clinical severity score (VCSS) was 8 (range, 6-9). Clinical
lassification using the CEAP descriptors revealed 15 patients at C2, 3 at C3,
nd 3 at C4. All patients underwent MECA of the GSV. No small saphenous
eins were treated. Twelve axial veins were accessed at the below knee
osition (2 at the ankle) and one above the knee. Concomitant stab
hlebectomies were performed in 11 patients.
Results: At the 48-hour follow-up duplex examination, 13 GSVs
emonstrated no flow, 2 exhibited partial flow, and 1 remained widely
atent. Postprocedural duplex studies revealed normal deep venous systems
n all patients. All 15 patients demonstrated improved VCSS scores. There
ere no postoperative complications.
Conclusions:Mechanical chemical ablation of the great saphenous vein is
promising therapeutic modality. Further evaluation is needed to evaluate
ong-term success and comparison with accepted endovenous techniques.
omparative Analysis of Femoropopliteal Versus Tibial Lesion Char-
cteristics that Predict Endovascular Therapy Success
n-Kyong Kim, MD, Natalia Egorova, PhD, Sikandar Z. Khan, MD, An-
rew J. Melzer, MD, James F. McKinsey, MD, New York-Presbyterian
ospital, Columbia University, New York, NY
Objective(s): Critical lesion characteristics that predict loss of patency
fter endovascular therapy (EVT) is poorly defined and has not been
pecified for respective lesion locations. This study differentiates the inde-
endent factors for femoropopliteal and tibial lesions and their comparative
mpact on patency.
Methods: All EVT for femoropopliteal and tibial artery lesions from
005 to 2009 at our institution were reviewed. Patency was evaluated by
aplan-Meier analysis and Cox proportional hazards regression.
Results: A total of 1776 discrete femoropopliteal or tibial lesions, or
oth, in 818 patients were treated. There were 1329 femoropopliteal lesions
n 675 patients (56.4%male; age, 72.4) and 447 tibial lesions in 275 patients
61.1% male; age, 71.9), and 17.5% of femoropopliteal lesions had concom-
tantly treated tibial lesion, and 45.9% of tibial presented with a femoropop-
iteal lesion. Overall 1-year primary patency rates were 61.5% for femoro-
opliteal and 60.0% for tibial lesions. Critical factors determining loss of
atency varied greatly between the lesion types: lesion calcification, which
ad a large effect on tibial patency, had no effect on femoropopliteal patency
P .0001). Multivariate Cox regression analysis revealed that independent
isk factors for loss of patency of femoropopliteal lesions were diabetes
hazard ratio [HR], 1.29; P .006), congestive heart failure (HR, 1.37; P
002), lesion length100 mm (HR, 1.64; P .0001), stenosis 80% to 99%
HR, 1.43; P  .003), and chronic occlusion (HR, 1.73; P  .0001). In
ontrast, factors for tibial lesions were diabetes (HR, 1.78; P  .041) and
alcification (HR, 2.21; P  .0001; Table).
Conclusions: Factors that impact loss of patency after EVT differ for
emoropopliteal and tibial lesions, especially in lesion characteristics. Femoro-
opliteal patency ismost affected by the lesion length and the degree of stenosis,
hereas tibial by the presence of calcification. These differences in factors point
o a need for a location-specific lesion severity score to allow for comparison of
esions and the probability of successful endovascular intervention.
able. Independent factors that predict loss of patency
actor HR (95% CI) P
emoropopliteal lesions
Diabetes 1.29 (1.023-1.627) .0311
Congestive heart failure 1.367 (1.058-1.768) .0169
Length 100 mm 1.649 (1.351-2.012) .0001
80-90% stenosis 1.429 (1.128-1.811) .0031
100% stenosis 1.733 (1.327-2.263) .0001
ibial lesions
Diabetes 1.778 (1.023-3.090) .0413
Calcification 2.207 (1.509-3.229) .0001
